ERBB-2 gene overexpression and amplification in uterine sarcomas
- 31 December 2004
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 95 (3), 583-587
- https://doi.org/10.1016/j.ygyno.2004.07.041
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Different expression patterns of KIT, EGFR, and HER‐2 (c‐erbB‐2) oncoproteins between epithelial and mesenchymal components in uterine carcinosarcomaCancer Science, 2003
- A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targetsGynecologic Oncology, 2003
- HER2/neu overexpression: has the Achilles’ heel of uterine serous papillary carcinoma been exposed?Gynecologic Oncology, 2003
- Chromosomal aberrations in malignant gastrointestinal stromal tumors: correlation with c-KIT gene mutationCancer Genetics and Cytogenetics, 2001
- Immunohistochemical Study of c-erb B-2 Expression in Malignant Mixed Müllerian Tumors of the Female Genital TractJournal of Obstetrics and Gynaecology Research, 1996
- Epidermal growth factor receptor and c-erbB-2 oncoprotein expression in female genital tract carcinosarcomas (Malignant mixed müllerian tumors): Clinicopathologic study of 82 casesCancer, 1996
- The Expression of Epidermal Growth Factor Receptor, HER-2/Neu,p53, and Ki-67 Antigen in Uterine Malignant Mixed Mesodermal Tumors and AdenosarcomaGynecologic Oncology, 1996
- HER-2/neu expression: A major prognostic factor in endometrial cancerGynecologic Oncology, 1992
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptorNature, 1986